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ABSTRACT (222 words) 
Objective: 
To summarise the evidence on effectiveness of translational diabetes prevention 
programmes, based on promoting lifestyle change to prevent type-2-diabetes in real 
world settings; to examine whether adherence to international guideline 
recommendations is associated with effectiveness. 
Research Design and Methods:  
Bibliographic databases were searched up to July 2012. Included studies had a 
follow-up of >12-months and outcomes comparing change in body composition, 
glycaemic control, or progression to diabetes. Lifestyle interventions aimed to 
translate evidence from previous efficacy trials of diabetes prevention into ‘real world’ 
intervention programmes. Data were combined using random effects meta-analysis, 
and meta-regression considering the relationship between intervention effectiveness 
and adherence to guidelines.  
Results: 
25 studies met the inclusion criteria. The primary meta-analysis included 22 studies 
(24 study groups) with outcome data for weight loss at 12-months. The pooled result 
of the direct-pairwise meta-analysis shows that lifestyle interventions resulted in a 
mean weight loss of 2.32kg (95% CI: -2.92 to -1.72; I2=93.3%). Adherence to 
guidelines was significantly associated with a greater weight loss (an increase of 
0.4Kg per point increase on a 12-point guideline-adherence scale).  
Conclusions:  
Evidence suggests pragmatic diabetes prevention programmes are effective. 
Effectiveness varies substantially between programmes, but can be improved by 
maximising guideline adherence. However, more research is needed to establish 
optimal strategies for maximising both cost-effectiveness, and longer-term 
maintenance of weight loss and diabetes prevention effects.
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INTRODUCTION 
A major opportunity exists to drastically reduce the incidence of type 2 diabetes; a 
disease that has a huge impact on patients and health care systems worldwide. 
Large, high quality clinical trials (1-3) show that relatively modest changes in diet and 
physical activity reduce the incidence of type 2 diabetes by more than 50% for people 
with impaired glucose regulation. Impaired glucose regulation is an intermediate 
condition between normal glucose regulation and type 2 diabetes, which confers an 
increased risk of progression to type 2 diabetes (4). Indeed, within-trial data show 
that the rate of progression to type 2 diabetes at seven years of follow up was 
reduced to almost zero for people who had succeeded in making five modest lifestyle 
changes (2). The main drivers of diabetes prevention appear to be weight loss and 
physical activity (5, 6). However, a substantial challenge remains in translating these 
findings into routine clinical practice. The intensive and prohibitively expensive 
interventions used in clinical trials, to ensure lifestyle change, need to be translated 
into practical affordable interventions that are deliverable in real world health care 
systems and which, nevertheless, retain a reasonable degree of effectiveness (7).  
 
Since the publication of the original diabetes prevention clinical trials between 1996 
and 2001, a number of translational or “real world” diabetes prevention programmes 
(8, 9) have aimed to translate the evidence (1, 10-12). A meta-analysis of the 
evidence on translational interventions was published in 2010 (9). Although this 
review excluded 15 studies that were conducted in non-health care settings. A more 
recent meta-analysis was published in 2012 (13). However, the authors only focused 
on translation of evidence from the US Diabetes Prevention Programme and also 
included studies where up to half of the population already had diabetes. Other 
systematic reviews of diabetes prevention interventions have either not included a 
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meta-analysis (6, 8, 14-17) or have not focused on translational studies (3, 6, 15, 16, 
18-22). Overall, the systematic reviews conducted to date indicate that real-world 
diabetes prevention programmes vary widely in their effectiveness, although most 
produce lower levels of weight loss than the more intensive interventions used in the 
clinical efficacy trials (9).  Explaining this variation is important. If we can identify the 
components of lifestyle interventions that are reliably associated with increased 
effectiveness, this will inform the design of more efficient (cost-effective) diabetes 
prevention programmes.  
 
Recently published evidence based guidelines (23, 24) make distinct 
recommendations about which intervention components should be included to 
maximise the effectiveness of lifestyle interventions for diabetes prevention. Such 
recommendations include the use of group based interventions to minimise cost and 
the use of specific behaviour change strategies that are associated with increased 
effectiveness. These recommendations come from systematic reviews of the wider 
literature on supporting changes in diet and physical activity in a range of populations 
(25, 26). Lifestyle interventions for diabetes prevention vary in their content, however, 
whether closer adherence to the guideline recommendations might improve the 
performance of real-world diabetes prevention interventions remains unclear. To 
consolidate the evidence, we undertook a systematic review of studies considering 
the effectiveness of translational interventions for prevention of type 2 diabetes in 
high risk populations. The primary aim was to conduct a meta-analysis of the 
effectiveness of pragmatic interventions on weight loss, and conduct a meta-
regression to examine whether closer adherence to guideline recommendations for 
diabetes prevention improves the effectiveness of real world interventions. If 
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sufficient data were available, a secondary aim was to consider other diabetes risk 
factors using similar methods. 
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METHODS 
Search strategy and study selection 
We included experimental and observational studies that considered the 
effectiveness of a lifestyle intervention (diet and/or exercise), alone or compared to 
control; where the stated aim of the intervention was diabetes risk reduction or 
prevention of type 2 diabetes; where the focus of the study was to translate evidence 
from previous diabetes efficacy trials into routine healthcare, or a community setting. 
For studies to be eligible for inclusion, we required them to include adults (>18 years 
old) identified as being at high risk of developing type 2 diabetes (for example, 
obese, sedentary lifestyle, family history of diabetes, older age, metabolic syndrome, 
impaired glucose regulation, pre-diabetes, or elevated diabetes risk score) (24); have 
a minimum follow-up of 52 weeks; and have an outcome relating to diabetes risk, as 
measured by a change in body composition or a change in glycaemic control, or 
report progression to diabetes (incidence or prevalence). The focus of the review was 
primary prevention, therefore, we excluded trials where >10% of the population had 
established diabetes. We included only studies published in English language and as 
full-length articles.  
 
We searched EMBASE, MEDLINE and The Cochrane Library (Issue 7, 2012), using 
a combination of MeSH terms and keywords which were tailored to individual 
bibliographic databases. We restricted searches to articles published after January 
1998; the starting point of 1998 was chosen to facilitate the identification of studies 
that were informed by or translating evidence from previous diabetes prevention 
efficacy trials (1, 10-12). In order to avoid missing papers the final search strategy 
included only terms related to the intervention and the study design. An example 
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search strategy (MEDLINE) is outlined in Supplemental Table S1. We combined the 
results of an initial search and an updated supplementary search, which together 
identified papers up to the end of July 2012.  
 
Two reviewers independently assessed abstracts and titles for eligibility and retrieved 
potentially relevant articles, with differences resolved by a third reviewer where 
necessary. Where studies appeared to meet all the inclusion criteria but data were 
incomplete, we contacted authors for additional data and/or clarification. In an 
attempt to identify further papers not identified through electronic searching, we 
examined the reference lists of included papers and relevant reviews. 
 
Data extraction and quality assessment 
Data were extracted by one reviewer and a second reviewer subsequently checked 
for consistency. We extracted data on sample size, population demographics, 
intervention details and length of follow-up. Where available, we recorded outcome 
data for the mean change from baseline to 12-months follow-up for the following 
outcomes: weight, body mass index (BMI), waist circumference, fasting glucose, 2-
hour glucose, glycated haemaglobin (HbA1c), total cholesterol, LDL cholesterol, HDL 
cholesterol, triglycerides, systolic blood pressure (BP), and diastolic BP. Incidence of 
type 2 diabetes was also recorded. We retrieved all papers relating to a particular 
study, including those on design and methodology (if reported separately), and any 
supplementary online material. 
 
We assessed the quality of selected studies according to the UK’s National Institute 
for Health and Clinical Excellence (NICE) quality appraisal checklist for quantitative 
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intervention studies (27).  The checklist includes criteria for assessing the internal 
and external validity of experimental and observational quantitative studies 
(randomized controlled trials (RCTs), non-randomised controlled trials, before and 
after studies) and allows assignment of an overall quality grade (categories ++, + or -
).  
 
Coding of intervention content 
We coded intervention content (see Supplemental Tables S2 and S3), in relation to 
the recommendations for lifestyle interventions for the prevention of diabetes 
provided by both the IMAGE project (Development and Implementation of a 
European Guideline and Training Standards for Diabetes prevention) (23) and NICE 
(24). Where a study intervention was inadequately described, we requested further 
details from the authors. If available information was insufficient to allow coding, we 
coded data as missing; where an intervention appeared to be well described but a 
particular component (e.g. engaging social support) was not mentioned or could not 
be implied from other text, we assumed that the component was not used. In the 
analysis, we assumed that missing values indicated that the guideline criterion was 
not met. 
 
Data synthesis and analysis 
We converted all values reported in imperial units, into metric units. Capillary blood 
glucose values were converted to plasma equivalent values (28). If studies did not 
directly report the mean and standard deviation (SD), for change from baseline to 12 
months for the outcomes of interest, they were calculated. We calculated the mean 
change by subtracting the baseline mean value from the mean at 12-months. We 
                      9 
calculated the SD from reported p-values or confidence interval (CI), as 
recommended by the Cochrane Collaboration (29). Where data were insufficient, to 
allow calculation of the SD, we imputed values for each outcome based on the 
correlation estimates from those studies that reported; for weight the correlation used 
in these imputations was 0.95 (30-34). 
 
For the primary outcome of interest (weight), we conducted a direct-pairwise 
comparison meta-analyses to examine the effect size (change from baseline to 12-
months), where data were available. Only intervention arms were included in the 
meta-analysis. This was because we were interested in whether adherence to 
guidelines improved weight loss; therefore, only arms in which people received an 
intervention were applicable. Meta-regression was used to assess the relationship 
between weight change at 12-months and the total IMAGE guidance score and the 
total NICE guidance score, as explanatory variables, in separate uni-variate 
analyses. We performed further meta-regression with the individual guideline 
components as the explanatory variables, where at least 3 studies fell into each 
category. We conducted similar analyses for the secondary outcomes of interest; 
however, as these outcomes were reported in fewer studies and to avoid multiple 
testing, meta-regression of individual guideline components against secondary 
outcomes was not performed. We performed sensitivity analyses for the primary 
outcome, weight, where missing guideline data were treated as unknown and a total 
guidance score was not given for those studies, and where we restricted the analysis 
to RCTs only. 
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We assessed publication bias using Egger’s test and heterogeneity using the I2 
statistic. Due to high levels of heterogeneity, we used random effects models 
throughout to calculate effect sizes.  We performed all analyses in Stata version 12.1 
(StatCorp, College Station, Texas, US).  
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RESULTS 
Identification of studies 
Results relating to identification and selection of eligible trials are summarised in 
Figure 1. Searches yielded 6326 citations and 3872 unique titles and/or abstracts 
were screened for eligibility. Following full text retrieval of 114 potentially relevant 
papers, twenty additional papers were identified from reference lists making a total of 
134. Authors for 13 studies were then contacted in order to clarify eligibility criteria 
and/or for additional outcome data. Replies were received for 12 studies, 10 of which 
were subsequently included in the 25 studies (30-54) (35 papers (30-64)) that met 
the review criteria. 
 
Summary of included studies 
The 25 studies (30-54) included in the systematic review are summarized in Table 1. 
Study interventions included either dietary intervention, physical activity intervention 
or both. Standard/brief advice on diet and/or exercise was considered to be 
comparable with usual care and not judged to be an active intervention. One study 
focused solely on the effectiveness of physical activity intervention (54), one 
combined dietary intervention and a supervised exercise programme (44), and 23 
studies considered the effectiveness of combined dietary and physical activity 
intervention. Eleven of the studies were RCTs, 11 were before and after studies and 
the remaining studies included a matched cohort, a prospective cohort and a non-
randomised controlled trial. All papers were published within the last 10 years.   
 
Studies were conducted in the US (n = 11), Australia (n = 2), Europe (n = 11) and 
Japan (n = 1); however, ethnicity was poorly reported. The number of people who 
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were enrolled into the intervention arm in individual studies ranged from 8 to >2700 
with 22 studies including at least 50 participants. The criteria used, alone or in 
combination, to identify high risk included: elevated BMI, elevated diabetes risk score 
(FINDRISC (65), ADA (66)), raised random, fasting or two-hour glucose (finger prick 
or venous sample); older age; ethnicity; family history of diabetes; previous medical 
history of cardiovascular disease, polycystic ovary syndrome, gestational diabetes, 
metabolic syndrome, elevated BP or lipids. Length of follow-up ranged from 12 
months to around 4 years. The mean age and BMI of participants ranged from 38 - 
65 years and 25 – 37 kg/m2 respectively, and the proportion of males ranged from 7 
– 66%.  
 
Outcome data for change in weight were available for 24/25 studies (not Costa (39)); 
22/25 studies reported weight at 12 months, see Supplemental Table S4.  Additional 
12 month data reported for 23 studies (Supplemental Tables S4 and S5) included 
change in BMI (18 studies), waist size (16), fasting glucose (15), 2 hour glucose (10) 
HbA1c (7), total cholesterol (13), LDL (7), HDL (12), triglycerides (10), systolic BP 
(13), diastolic BP (11), and the incidence of diabetes after 12-months (8). Outcome 
data for change in physical activity and diet were poorly reported. Overall, 
considerable heterogeneity was evident between studies in relation to several key 
characteristics including the setting, population, criteria used to identify diabetes risk, 
interventions and follow-up.  
 
Study quality 
A breakdown of study quality is presented in Supplemental Table S6. Most studies 
achieved a high quality grading for internal validity (19/25). However, details relating 
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to the source/eligible population and area, and the selected participants were less 
well reported; only 11 studies achieved a high quality score for external validity. 
 
Scoring of intervention content 
Details of coding scores for study interventions are presented in Supplemental Table 
S3. Fourteen of the 25 intervention groups included in the main meta-analysis 
attained an overall score of ≥9 out of a possible 12, in relation to meeting NICE 
guideline recommendations; 19 scored ≥7. For IMAGE guideline recommendations, 
an overall score of ≥5 out of a possible 6 was achieved by 12 study groups.  
 
Meta-analysis  
Twenty two studies involving 5500 participants (estimated 43% male), were included 
in the meta-analysis for mean weight change at 12-months One study was excluded 
from the primary meta-analysis as weight change was not recorded as a study 
outcome (39) and two studies were excluded from all analyses as they only reported 
18-month data (45, 53). Two studies included in the meta-analysis had two 
intervention arms (43, 54), meaning that 24 study groups were analysed.  
 
The pooled result of the direct-pairwise meta-analysis (Figure 2) shows that lifestyle 
interventions resulted in a mean weight loss of 2.32kg (95% CI: -2.92 to -1.72; 
I2=93.3%). Supplemental Figures S1 and S2 show the meta-regression results for the 
NICE and IMAGE guidelines for weight, respectively. Greater adherence to guideline 
recommendations was significantly associated with greater weight loss for both sets 
of guidelines (Table 2). Adherence to individual guideline elements also tended to 
result in greater weight loss, some of which were statistically significant (Table 2). 
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Sensitivity analyses without imputed data are also shown in Table 2. This showed 
that, where data were complete, the effect sizes were generally larger for both NICE 
and IMAGE guidance, -0.52 kg per point increase on the 12-point adherence scale 
(95% CI: -0.95 to -0.10) and -0.77 kg per point increase on the 6-point adherence 
scale (95% CI: -1.28 to -0.26) respectively. 
 
None of the study level co-variates (proportion of males, mean age, proportion of 
White European ethnicity) were significantly associated with the mean difference in 
weight change. Sensitivity analysis, restricted to RCTs only, indicated a mean weight 
change (-2.7kg; 95% CI: -4.2 to -1.2kg) that is similar to the overall result. Additional 
analysis comparing the difference in weight lost between the treatment and control 
arms, for RCTs only, suggests that on average the intervention arm lost an extra -
1.93kg (95% CI -3.10 to -0.76kg; p=0.001). Furthermore, sensitivity analyses which 
included studies scoring ++ for external validity demonstrated a slightly greater 
weight loss in higher quality studies (-3.1kg; 95% CI: -4.6 to -1.6kg). Additionally, 
there was very limited evidence of publication bias (p=0.05, Egger’s test).  
 
All other outcomes showed an improvement at 12 months, see Supplemental Table 
S7, but not all of these reached statistical significance. Supplemental Table S8 
shows the effect of adherence to NICE and IMAGE guidelines on the other 
outcomes. For both NICE and IMAGE guidelines respectively, greater adherence 
resulted in better outcomes for waist circumference (-0.52cm, p=0.007; -0.80cm, 
p=0.001) and triglycerides (-0.03mmol/l, p=0.016; -0.04mmol/l, 0.023). For BMI the 
improvements were only significant for adherence to NICE guidelines (-0.12kg/m2, 
p=0.028). There was no effect on any of the other outcomes. Across the 8 studies 
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that reported incident diabetes, the pooled incidence rate was 34 cases per 1000 
person-years (95% CI: 22 to 56), which gives the number needed to treat (NNT) as 
29. 
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DISCUSSION 
The 22 translational diabetes prevention programmes included in our meta-analysis 
significantly reduced weight in their intervention arms by a mean 2.3Kg at 12 months 
of follow up. Where data were available, we found significant reductions in other 
diabetes and cardiovascular risk factors, including blood glucose, blood pressure and 
some cholesterol measures. Adherence to guideline recommendations on 
intervention content and delivery was significantly associated with a greater weight 
loss such that, for each 1 point increase on the 12-point scale for adherence to NICE 
recommendations an additional 0.4Kg (p=0.008) of weight loss was achieved; 
furthermore, for waist size  a significant reduction of 0.5cm was achieved for each 
point increase. The pooled diabetes incidence rate was 34 per 1000 person-years 
(NNT 29). Outcome data on changes in the key lifestyle behaviour targets (physical 
activity and diet) were poorly reported. 
 
Relationship to other literature 
The mean level of weight loss achieved was around a half to one third of the levels 
reported at the same time point within the intervention arms of clinical efficacy trials 
such as the US DPP (∼6.7Kg) and the Finnish DPS (∼4.2Kg) (1, 10). This is 
consistent with the findings of a meta-analytic systematic review published in 2010 by 
Cardona et al (9) which identified a mean net weight loss after 12 months of 1.82Kg 
(95%CI:-2.7 to -0.99 Kg). Cardona et al interpreted the lower level of weight loss and 
a lack of significant differences in fasting plasma glucose and 2 hour glucose, as 
meaning that the interventions “appear to be of limited clinical benefit”. Our view is 
that, despite the drop-off in intervention effectiveness in translational studies, the 
level of weight loss found in our analysis is still likely to have a clinically meaningful 
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effect on diabetes incidence. This is based on data from the US DPP study which 
show that each kilogram of mean weight loss is associated with a reduction of around 
16% in future diabetes incidence (5). Furthermore, a recent meta-analysis, which 
included studies without an intervention in order to look at natural diabetes 
progression rates in high risk individuals, found progression rates to diabetes from 
IFG, IGT and both were 47, 56 and 76 per 1000 person-years respectively (67).  The 
rate of 34 per 1000 person-years that we found suggests that the real world lifestyle 
interventions studied here did lower diabetes progression rates. 
 
For our review, the mean proportion of weight lost (%) at 12 months follow-up was -
2.6%. This amount was slightly lower than was demonstrated by a recent meta-
analysis conducted by Ali et al, which considered translational studies aimed at 
populations with existing diabetes (≤50%) or at high future risk (13). They found a 
mean weight loss of −4.1% (95%CI: −5.9 to −2.4%) after at least 9 months of follow-
up (13). This difference may in part be due to a lower mean BMI at baseline for 
studies included in our review, compared to the Ali et al review (range 25-36kg/m2 
and 31-40kg/m2 respectively), and a slightly longer follow-up period (12 months vs. 
≥9). Additionally, their review focused on interventions based only on the US 
Diabetes Prevention Programme where we considered a broader set of interventions.  
 
Changes in the four key dietary and physical activity targets (≤30% energy from fat, 
≤10% energy from saturated fat, fibre ≥15 g/1,000 kcal, ≥30 minutes moderate 
physical activity daily) have also been shown to have independent effects on 
diabetes risk reduction, irrespective of weight loss (5). However, few of the studies 
we examined provided data on dietary intake or physical activity, so we cannot be 
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sure whether diabetes prevention in these studies is driven by increased physical 
activity, dietary change or both. 
 
The strong association between increased weight loss and increased adherence to 
guideline recommendations is of particular interest. Where complete data were 
available, the coefficients were larger: -0.52Kg per point increase (95% CI: -0.95 to -
0.10) for adherence to NICE guidance, on a 12-point scale; -0.77 Kg per point 
increase (95% CI: -1.28 to -0.26) for adherence to IMAGE guidance, on a 6-point 
scale. This may reflect a reduction in the statistical ‘noise’ caused by missing data, or 
it may reflect the fact that studies that had a stronger behavioural science input were 
more likely to report the intervention content in detail (and were also more likely to be 
effective). Overall, these data suggest that a high proportion of the variation in weight 
loss could be explained by variations in intervention design. The implication is that a 
design based on guideline recommendations should lead to performance at the 
higher end of the range (4 Kg or more).  
 
Strengths and Limitations 
This study is novel in that it provides an updated meta-analysis of a global set of 
lifestyle interventions for diabetes prevention.  Our study used comprehensive search 
criteria and focused on establishing the utility of pragmatic attempts to achieve 
diabetes prevention in real-world service delivery settings. It also provides novel data 
that appear to validate the usefulness of recent guideline based recommendations on 
the content of lifestyle interventions for diabetes prevention.  
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The study is limited in that there was insufficient data to analyse outcomes beyond 
12 months; our findings may not translate into long-term therapeutic value due to 
uncertainty around sustaining outcomes, such as weight loss, in the longer term.(68) 
Furthermore, results in individual studies were not always reported on an intention-to-
treat basis, leading to a likely overestimation of effect sizes. Assuming no change in 
weight for those with missing data, sensitivity analyses that we conducted suggest 
that weight loss could be up to 0.5kg less in practice than the figures reported in the 
studies.  
 
Due to the nature of pragmatic implementation studies, which include a number of 
uncontrolled studies, our analysis was restricted to intervention arms only; however, 
sensitivity analysis, restricted to RCTs only, indicated a mean weight change (-2.7kg; 
95% CI: -4.2 to -1.2kg) that is similar to the overall result. These findings suggest that 
the estimate based on intervention arms only is likely to be robust.  
 
Implications for practice 
Our review suggests that pragmatic lifestyle interventions are effective at promoting 
weight loss and could potentially lead to a reduced risk of developing diabetes and 
cardiovascular disease in the future. However, the difficulties in translating this 
evidence into practice and in delivering guideline-based interventions need to be 
overcome. The ability to implement these findings in practice may be further 
hampered by a lack of resource for service provision, the design of efficient risk 
identification systems, and engagement of politicians and health care organisations 
in funding national diabetes prevention programmes; diabetes prevention strategies 
require substantial up-front investment to accrue longer-term benefits (7). 
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Future directions 
More research is needed to examine the longer-term effectiveness and cost-
effectiveness of pragmatic lifestyle interventions for diabetes prevention, including 
diabetes incidence as well as weight loss outcomes. The practical value of diabetes 
prevention interventions would be much clearer if we had data on longer-term 
outcomes. Research is also needed to identify the role of different types of physical 
activity and dietary changes (6, 69) and on ways to increase effectiveness without 
increasing cost. Possible approaches might include the use of larger group sizes and 
substitution or supplementation of intervention techniques using self-delivered 
formats (e.g. internet, smart phone or workbook) (70). 
 
Conclusion 
Overall, the interventions were effective, but there was wide variation in 
effectiveness. Adherence to international guidelines on intervention content and 
delivery explained much of the variance in effectiveness, implying that effectiveness 
could be improved by maximising guideline adherence. However, more research is 
needed to establish optimal strategies for maximising both cost-effectiveness and 
longer-term maintenance of the lifestyle changes that these programmes can 
achieve. 
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FIGURE LEGENDS 
 
Figure 1: Flow chart of selection of studies from search to final inclusion 
 
Figure 2. Forest plot showing mean weight change in each study and the overall 
pooled estimate 
Boxes and horizontal lines represent mean weight change and 95% CI for each study. Size of 
box is proportional to weight of that study result. Diamonds represent the 95% CI for pooled 
estimates of effect and are centred on pooled mean weight change.
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study 
groups 
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Setting Country Ethnicity 
% 
Age 
(mean) 
Male 
(%) 
BMI 
(mean 
kg/m2) 
Absetz 2007 
(& 2009) 
Before & 
after 
GOAL Aged 50-65 years; Any risk 
factor from obesity, ↑BP, 
↑plasma glucose, ↑lipids; 
FINDRISC score ≥12 
Lifestyle (Diet 
& exercise) 
352 1 12 & 36 Primary care Finland N/R 58 (F); 
59 (M) 
25 33 
(F); 
32 
(M) 
Ackermann 
2008 (& 
2011) 
RCT DEPLOY BMI ≥24 & ADA diabetes risk 
score ≥10; CBG random (110 – 
199 mg/dl) or fasting (100 – 
199 mg/dl) 
Lifestyle (Diet 
& exercise) 
92 2 12 Community 
(YMCA) 
US 82% 
White, 3% 
Hisp, 12% 
Af-Am, 5% 
other 
58 45 31 
Almeida 
2010 
Matched 
cohort 
KPCO Existing IFG (110 – 125mg/dl) 
identified from medical records 
Lifestyle (Diet 
& exercise) 
1640 (1520 
data 
available) 
2 12 Integrated 
healthcare 
organisation 
US N/R 55 47 30 
Boltri 2008 Before & 
after 
DPP in faith 
based 
ADA diabetes risk score ≥10; 
CBG fasting (100 – 125mg/dl) 
Lifestyle (Diet 
& supervised 
exercise) 
8 1 12 Community 
(Church) 
US Af-Am 
community 
52* 42* 32 
Costa 2012 Prospective 
cohort 
DE-PLAN 
Spain 
FINDRISC score ≥14 or 2hr 
OGTT (≥7.8 and <11.1mmol/l) 
Lifestyle (Diet 
& exercise) 
552 
(219+333) 
2 Median 
4.2yrs 
Primary care Spain White-
European 
62 32 31 
Davis-Smith 
2007 
Before & 
after 
N/R ADA diabetes risk score ≥10; 
CBG fasting (100 – 125mg/dl) 
Lifestyle (Diet 
& exercise) 
11 1 12 Community 
(Church) 
US Af-Am 
community 
N/R 27 36† 
 
Faridi 2010 Non-
randomised 
controlled 
trial 
PREDICT 1 or more risk factor from BMI 
≥25, FH diabetes, gestational 
diabetes 
Lifestyle (Diet 
& exercise) 
146 2 12 Community 
(Church) 
US Af-Am 
100% 
N/R 32 33 
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Study 
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Intervention(s) 
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overall (& 
by group) 
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study 
groups 
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up 
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Setting Country Ethnicity 
% 
Age 
(mean) 
Male 
(%) 
BMI 
(mean 
kg/m2) 
Gilis-
Januszewska 
2011 
Before & 
after 
DE-PLAN 
Poland 
FINDRISC score ≥14 Lifestyle (Diet 
& exercise, 
optional 
supervised 
sessions) 
175 1 12 Primary care Poland NR NR 22 32 
Katula 2011 RCT HELP PD BMI ≥25 <40 & CBG random; 
FPG (95 - 125 mg/dl) 
Lifestyle (Diet 
& exercise) 
301 (151 + 
150) 
2 12 Community 
various 
venues 
US 74% 
White, 
25% Af-
Am, 1% 
other 
58 43 33 
Kramer 
2009 
Before & 
after 
GLB 2005 – 
2008 
BMI ≥25 & metabolic 
syndrome or CBG fasting (100 
– 125mg/dl) 
Lifestyle (Diet 
& exercise) 
42 1 12 Primary care 
& university 
based 
support 
centre 
US White 
100% 
57 21 35 
Kramer 
2012 
Before & 
after 
GLB 2009 Fasting glucose 100 – 125mg/dl Lifestyle (Diet 
& exercise) 
60 (31+29) 2 12 Community 
(YMCA) 
and 
university 
US 90% 
Caucasian 
55 35 ~36 
Kulzer 2009 RCT PREDIAS FINDRISC score ≥10 or 
assessed as ↑risk diabetes by 
primary care physician 
Lifestyle (Diet 
& exercise) 
182 (91 + 
91) 
2 12 Outpatient 
setting 
Germany N/R 56 57 32 
Laatikainen 
2007 (& 
2012) 
Before & 
after 
GGT study FINDRISC score ≥12 Lifestyle (Diet 
& exercise) 
311 1 12 Primary care Australia N/R 57 28 34 
Makrilakis 
2010 
Before & 
after 
DE-PLAN 
Greece 
FINDRISC score ≥15 Lifestyle (Diet 
& exercise) 
191 1 12 Primary 
care, 
workplace 
Greece NR 56 40 32 
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Year 
Study 
design 
Study name Definition of high risk of 
T2DM 
Focus of 
Intervention(s) 
No 
recruited 
overall (& 
by group) 
No 
study 
groups 
Follow-
up 
(months) 
Setting Country Ethnicity 
% 
Age 
(mean) 
Male 
(%) 
BMI 
(mean 
kg/m2) 
Mensink 
2003 (& 
2003) 
(Roumen 
2008 & 
2011)  
RCT SLIM study Aged >40 years & FH diabetes 
or BMI ≥25; IGT (OGTT 2hrG  
≥7.8 & <12.5) & FPG <7.8 
Lifestyle (Diet 
& supervised 
exercise) 
114 (55 + 
59) 
2 12, 24, 
36, 48 
(Roumen) 
unclear Netherlands White 
caucasian 
57 56 30 
Nilsen 2011 RCT APHRODITE 
study 
FINDRISC score ≥9 Lifestyle (Diet 
& exercise) 
213 
(104+109) 
2 18 Primary care Norway NR 47 50 37 
Ockene 
2012 
RCT Lawrence 
Latino DPP 
BMI≥24, >30% increased 
likelihood of diabetes over next 
7.5 from validated risk 
algorithm 
Lifestyle (Diet 
& exercise) 
312 
(150+162) 
2 12 Community, 
family 
health centre 
US 60% 
Dominican; 
40% Puerto 
Rican 
52 26 34 
Parikh 2010 RCT Project 
HEED 
BMI ≥25 & pre-diabetes; CBG 
fasting <126mg/dl & 2hr CBG 
following 75g glucose 
Lifestyle (Diet 
& exercise) 
99 (50 + 
49) 
2 12 Community 
various 
venues 
US 89% Hisp, 
9% Af-Am 
48 15 32 
Payne 2008 Before & 
after 
N/R Aged ≥45 years or aged ≥35 
Aboriginal, Torres Strait 
Islanders, Pacific Islanders, 
Indian, Chinese) & BMI ≥30 
&/or ↑BP; Existing CVD, 
PCOS, gestational diabetes; 1st 
degree FH diabetes; IGT or IFG 
Lifestyle (Diet 
& exercise 
program) 
122 (62 + 
60) 
2 12 Outpatient 
facility 
Australia N/R 53 22 35 
Penn 2009 RCT N/R BMI >25 & aged >40 years; 
IGT (OGTT 2hrG  ≥7.8 & 
<11.1) 
Lifestyle (Diet 
& exercise) 
102 (51 + 
51) 
2 12 & 3.1 
yrs mean 
Outpatient 
setting 
UK N/R 57 40 34 
Ruggiero 
2011 
Before & 
after 
N/R BMI≥24.9 Lifestyle (Diet 
& exercise) 
69 1 12 Community 
various 
venues 
US Hispanic 38 7 31 
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Author & 
Year 
Study 
design 
Study name Definition of high risk of 
T2DM 
Focus of 
Intervention(s) 
No 
recruited 
overall (& 
by group) 
No 
study 
groups 
Follow-
up 
(months) 
Setting Country Ethnicity 
% 
Age 
(mean) 
Male 
(%) 
BMI 
(mean 
kg/m2) 
Saaristo 
2010, 
(Rautio 
2011 & 
2012) 
Before & 
after 
FIN-D2D FINDRISC score ≥15 or IFG or 
IGT or CVD event or 
gestational diabetes 
Lifestyle (Diet 
& exercise) 
2798 1 12 Primary care Finland NR 54 49 ~31 
Sakane 2011 RCT N/R IGT identified as follows: IFG 
≥5.6 & <7.0; Random PG (≥7.8 
<11.1 within 2 hrs of meal) or 
(≥6.1 & <7.8, ≥2 hrs after 
meal); IGT 
Lifestyle (Diet 
& exercise) 
296 (146 + 
150) 
2 12 & 36 Various: 
primary 
care, 
workplace, 
collaborative 
centre 
Japan N/R 51 51 25 
Vermunt 
2012 (& 
2011) 
RCT N/R FINDRISC score ≥13 Lifestyle (Diet 
& exercise) 
925 
(479+446) 
2 18, 30 Primary care Netherlands NR NR NR ~29 
Yates 2009 
(& 2011) 
RCT PREPARE BMI ≥25 (23 for SAs); 
Screened detected IGT 
Lifestyle 
(Exercise) 
98 
(33+31+34) 
3 12, 24 Outpatient 
setting 
UK 75% † 
White, 
24% SA, 
1% Black 
65† 
 
66† 
 
29.2† 
 
*Boltri estimated from larger cohort (n = 26) who were screened with CBG;  † given for completers. Payne randomily allocated to 2 exercise groups but most results presented overall 
Abbreviations: ADA, American Diabetes Association; Af-Am, African American; BP, blood pressure; BMI, body mass index; CBG, capillary blood glucose; CI, confidence interval; CVD, 
cardiovascular disease; F, female; FH, family history; FINDRISC, Finnish Diabetes Risk Score; FPG, fasting plasma glucose;HbA1c, glycated haemoglobin; HDL, high density lipoprotein; Hisp, 
Hispanic; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; LDL, low density lipoprotein; M, male; N/R, not reported; OGTT, oral glucose tolerance test; PCOS, polycystic ovary 
syndrome; PG, plasma glucose; SA, South Asian; T2DM, type 2 diabetes 
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Table 2. Meta-regression results for weight change from baseline to 12 months.  
Explanatory variable Number of 
studies 
Number of 
participants 
Effect (95% CI), kg P value 
NICE (continuous) 24 5500 -0.37 (-0.64, -0.11) 0.008 
NICE without imputation 
(continuous) 
17 4885 -0.52 (-0.95, -0.10) 0.020 
IMAGE (continuous) 24 5500 -0.56 (-0.96, -0.17) 0.008 
IMAGE without imputation 
(continuous) 
18 4942 -0.77 (-1.28, -0.26) 0.006 
IMAGE B (continuous) 24 5500 -0.61 (-0.99, -0.22) 0.004 
IMAGE B without imputation 
(continuous) 
18 4942 -0.78 (-1.26, -0.29) 0.004 
Engage social support (yes vs no) 24 5500 -1.58 (-3.06, 0.10) 0.037 
Number of contacts (freq) 23 5417 -0.09 (-0.13, -0.05) <0.001 
Contact time (hours) 23 5147 -0.15 (-0.21, -0.08) <0.001 
≥16 hours of contact time (yes vs 
no) 
23 5147 -2.20 (-3.61, -0.79) 0.004 
Self-regulatory techniques (yes vs 
no) 
24 5500 -1.17 (-3.00, 0.66) 0.200 
Empathy-building approach (yes vs 
no) 
24 5500 0.86 (-0.71, 2.43) 0.269 
Spread sessions over 9-18 months 
(yes vs no) 
24 5500 -1.62 (-3.07, -0.18) 0.029 
Motivation (yes vs no) 24 5500 -1.49 (-3.05, 0.07) 0.060 
Gradual building of confidence (yes 
vs no) 
24 5500 -0.58 (-2.24, 1.08) 0.477 
Fidelity (yes vs no) 24 5500 -0.79 (-2.59, 1.02) 0.377 
Additional physical activity sessions 
(yes vs no) 
24 5500 -0.53 (-2.62, 1.56) 0.604 
 
Abbreviations: CI, confidence interval; IMAGE, Development and Implementation of a European 
Guideline and Training Standards for Diabetes prevention; NICE, National Institute for Health and 
Clinical Excellence (Preventing type 2 diabetes: Risk identification and interventions for individuals at 
high risk). 
